Brief: Cocrystal Pharma Presents Preclinical Data From Covid-19 Antiviral Programs
01/12/2021 21:36
Dec 1 (Reuters) - Cocrystal Pharma Inc COCP.O :
* COCRYSTAL PHARMA PRESENTS PRECLINICAL DATA FROM COVID-19
ANTIVIRAL PROGRAMS AND OUTLINES NEAR-TERM CLINICAL PLANS AT THE
WORLD ANTIVIRAL CONGRESS 2021
Source text for Eikon: ID:nGNX2x0StZ
Further company coverage: COCP.O
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway